Advertisement
Advertisement
U.S. Markets close in 56 mins
Advertisement
Advertisement
Advertisement
Advertisement

Nippon India Overnight Fund Regular Quarterly Dividend Payout (0P0001FB9O.BO)

BSE - BSE Delayed Price. Currency in INR
100.500.00 (0.00%)
At close: 01:30AM IST
Advertisement
Full screen
Previous Close0.00
YTD Return1.01%
Expense Ratio (net)0.00%
CategoryN/A
Last Cap GainN/A
Morningstar Rating★★★★★
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
Yield2.89%
5y Average ReturnN/A
Holdings TurnoverN/A
Last Dividend0.70
Average for CategoryN/A
Inception DateDec 18, 2018
  • GlobeNewswire

    Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing

    NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 23rd Life Sciences Investor Forum are now available for on-demand viewing. REGISTER NOW OR LOGIN AT: https://bit.ly/3nbZJuOThe company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Companies are accepting 1x1 manag

  • PR Newswire

    Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy

    Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the Italian Medicines Agency, or Agenzia Italiana del Farmaco (AIFA), has authorized Alterity to conduct its Phase 2 clinical trial of ATH434 in Multiple System Atrophy (MSA), a rare and highly debilitating Parkinsonian disorder.

  • GlobeNewswire

    UPDATE - Life Sciences Investor Forum: Company Executives Present Live June 23rd

    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with Zacks Small-Cap Research, today announced the agenda for the upcoming Life Sciences Investor Forum to be held on June 23rd. Individual investors, institutional investors, advisors, and analysts are invited to attend. The program begins at 9:30 AM EDT on Thursday,

Advertisement
Advertisement